New therapeutic target for metabolic syndrome: PPARdelta.
Takahashi
Sadao
S
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan.
Tanaka
Toshiya
T
Sakai
Juro
J
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy / Q000209:etiology; D050260:Carbohydrate Metabolism / Q000235:genetics; D004734:Energy Metabolism / Q000235:genetics / Q000502:physiology; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D024821:Metabolic Syndrome / Q000188:drug therapy*; D051379:Mice; D018345:Mice, Knockout; D008954:Models, Biological; D018482:Muscle, Skeletal / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics; D010084:Oxidation-Reduction; D047494:PPAR delta / Q000819:agonists* / Q000235:genetics / Q000502:physiology; D020641:Polymorphism, Single Nucleotide
D005227:Fatty Acids; D008074:Lipoproteins; D047494:PPAR delta